Overview

Tolvaptan in Hyponatremic Cancer Patients

Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if tolvaptan can help raise salt (sodium) levels in the cancer patients' blood by removing extra body water as urine.
Phase:
Phase 4
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborator:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Treatments:
Tolvaptan